Elaine Alison Irving

Title: Elaine Alison Irving: Innovator in Stroke Treatment

Introduction

Elaine Alison Irving is a prominent inventor based in Stevenage, GB. She has made significant contributions to the field of medical science, particularly in the treatment of stroke. With a total of 2 patents to her name, her work focuses on innovative therapeutic methods that utilize anti-MAG antibodies.

Latest Patents

Irving's latest patents include groundbreaking inventions aimed at improving stroke treatment. The first patent, titled "Treatment of stroke comprising anti-MAG antibodies," outlines a dosing regimen for the administration of two doses of anti-MAG antibodies specifically for the treatment of ischemic and/or hemorrhagic stroke. The second patent, "Therapeutical use of anti-myelin associated glycoprotein (MAG) antibodies," describes a method for promoting oligodendrocyte survival in individuals suffering from or at risk of developing stroke or other neurological diseases through the use of anti-MAG antibodies or their functional fragments.

Career Highlights

Elaine Irving is associated with Glaxo Group Limited, where she continues to advance her research and innovations in the medical field. Her work has the potential to significantly impact the treatment of neurological conditions, particularly stroke.

Collaborations

Irving collaborates with talented professionals in her field, including Mary Vinson and Bams Abila. Their combined expertise contributes to the development of effective treatments and therapies.

Conclusion

Elaine Alison Irving is a dedicated inventor whose work in stroke treatment showcases her commitment to advancing medical science. Her innovative patents reflect her significant contributions to improving patient outcomes in neurological health.